ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BVXP Bioventix Plc

4,450.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix Plc LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4,450.00 4,400.00 4,500.00 4,450.00 4,450.00 4,450.00 16,374 07:47:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 12.82M 8.37M 1.6071 27.69 231.82M
Bioventix Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker BVXP. The last closing price for Bioventix was 4,450p. Over the last year, Bioventix shares have traded in a share price range of 3,450.00p to 5,060.00p.

Bioventix currently has 5,209,333 shares in issue. The market capitalisation of Bioventix is £231.82 million. Bioventix has a price to earnings ratio (PE ratio) of 27.69.

Bioventix Share Discussion Threads

Showing 1101 to 1122 of 1575 messages
Chat Pages: Latest  51  50  49  48  47  46  45  44  43  42  41  40  Older
DateSubjectAuthorDiscuss
22/10/2019
10:18
down down deeper and down


status quo



Just sayin


18 quid could be comung

onjohn
22/10/2019
07:21
Ta muchly Boros10.

Just from the tone of the medical articles about hs-troponin introduction and the associated protocols I expect them to beat the finnCap estimates. I had not understood that BVXP would be responsible for the pollution diagnostic. I guess/hope production and distribution will be farmed out.

apad

apad
22/10/2019
06:33
Freely available (subject to registration) FinnCap report here:
carcosa
21/10/2019
23:17
I'm sorry about earlier. Someone contacted me via twitter and I thought it was you so gave them the call details. I couldn't find your message via ADVFN. The meeting was very positive. Management appear very confident of hitting finnCap's Troponin forecast of £500k in the current year and £1.1m next. They also seem very hopeful on the prospects for the pollution diagnostic. I got the impression they have made very good progress in developing the antibody or antibodies required but their thinking about how to manufacturer the diagnostic and the route to market are less advanced. It would be the first time that Bioventix has created a diagnostic. They believe customers would include research institutions and members of the public. One key positive is that FDA approval would not be required to launch the test.
boros10
21/10/2019
18:56
Any feedback from the Finncap meeting, Leon?
apad

apad
21/10/2019
13:39
What is the PE here. Looks a bit high to me.
nobilis
21/10/2019
13:28
Courtesy of bamboo on another thread, I think this has further to fall

BVXP, has historical support at 3150, 2990
Chart shows confirmed H&S [3000] and BARF [3200] patterns.

Potential turns 21/10 & 7/11/2019
Trades also on NEX:BVXP.GB

toptrump1
21/10/2019
13:15
Smells like Sheep dip
onjohn
21/10/2019
13:11
Leon,
Sent you an advfn message, twitter wouldn't let me message you 😊 You're obviously exalted!
apad

apad
21/10/2019
09:56
On John, I always listen to the opposite side of every debate as you learn very little new from those who agree with you so I look forward to hearing your arguments. I've no idea how to filter someone. It's not my style.
boros10
21/10/2019
09:48
You'd struggle to classify your comments as 'debate' John.
stepone68
21/10/2019
09:39
:)) filter me if you dont like. was a free country last time i looked,. if you dont like democratic debate then f o to north korea
onjohn
21/10/2019
09:36
Oh dear the Bioventix board discovered by Advfn rampster community. End of sensible debate?"OnJohnFalling on every small saledown 350p by end of day"
boros10
21/10/2019
09:30
Falling on every small sale


down 350p by end of day>

onjohn
21/10/2019
09:17
Apad - meeting today at FinnCap at 14:30. Let me have your full name and email address and I will see if I can get you in or on the telephone call. If you want to give me those details privately message me on Twitter at @Boros10
boros10
21/10/2019
09:04
This is off-topic, but following on from the Vitamin D comments, for those interested the following article presents an anti-supplement/pro-sunlight perspective:



"Yet vitamin D supplementation has failed spectacularly in clinical trials. Five years ago, researchers were already warning that it showed zero benefit, and the evidence has only grown stronger. In November, one of the largest and most rigorous trials of the vitamin ever conducted—in which 25,871 participants received high doses for five years—found no impact on cancer, heart disease, or stroke."

Of course, there are plenty of articles arguing the opposite too - but I think the case presented in the linked-to article is compelling.

spann_703
21/10/2019
08:56
Also, very curious to know what the £200k additional investment in Pre-Diagnostics post period end is for. I was under the impression that the money related to the beta amyloid clinical trials (EU Horizon + private) was raised some months ago.
gsbmba99
21/10/2019
08:30
Llooks a bearish head and shoulder pattern on the chart


£28 seems a target

onjohn
21/10/2019
08:28
Falling on every small sale
onjohn
21/10/2019
08:20
@stepone68 - agreed that the P/E has been high for a while. However I think what is currently different is that the market has been savage in its recent treatment of high P/E shares. On a personal note, I am also heavily overweight BVXP in portfolio percentage terms, so the decision to reduce was partly governed by that.

My previous comment may have sounded negative, but I still have a significant holding here. Like you I think the royalty model/moat and company metrics are outstanding, and I'm optimistic of long-term success.

spann_703
21/10/2019
08:15
I am hoping for a Harrison presentation but cannot find a notification.

Can anyone help?

Boros10 you write about quizing the management?

apad

apad
21/10/2019
08:07
Agreed the current revenue concentration around Vit D is a cause of concern, although I expect this to continue to grow strongly in Asia. A change in thinking on the benefits of Vit D is a risk but I can't see this happening anytime soon.Troponin should finally start to ramp up in 2019/20 as more hospitals and labs get their protocols in place. I was encouraged to see that finnCap's medium term view on Troponin royalties of up to £3.5m p.a. are broadly in line with my own forecasts. Other royalty streams grew strongly with many beating my own forecasts. The only setback were the royalties for its range of drug testing antibodies which dropped by more than 20% which I had expected to increase by a similar percentage. I'll need to quiz management on that today. The finnCap forecasts point to further material increases in EPS to 2021.
boros10
Chat Pages: Latest  51  50  49  48  47  46  45  44  43  42  41  40  Older

Your Recent History

Delayed Upgrade Clock